Search
Evaxion Biotech A/S
EVAXAdd to Watchlist
3.280USD
+0.010+0.31%
Close 09-23 16:00（ET）
29.59MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+0.31%
5 Days
+8.25%
1 Month
-0.91%
6 Months
-15.46%
Year to Date
-31.24%
1 Year
+8.61%
Key Figures
3.330Open
3.330High
1.50KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.02%Turnover Ratio
3.270Prev. Close
3.180Low
4.99KTurnover
LossP/E Static
3.15P/B
0.00%Div Yield TTM
-39.92%ROA
12.15052wk High
0.04Volume Ratio
-10.57MNet Profit
9.02MShares
-0.2080EPS TTM
0.26Beta
-82.85%ROE
2.77052wk Low
4.59%Amplitude
100.00%Gross Margin
29.59MMarket Cap
2.25Reward/Risk
7.05%Risk Rate
Evaxion Biotech A/S's Score
-0.08vs previous score
Forecast8.00
Financial Health7.14
Technical3.82
Valuation Dimensions9.78
Institutional Confidence3.00
Risk Assessment--
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Evaxion Biotech A/S Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Buy
Evaxion Biotech A/S Latest Earnings Call Transcripts
Evaxion (EVAX) Q2 2026 Earnings Call: $14M Cash and EVX-01 Update
Evaxion’s Q2 2026 earnings call covered a $3.7 million net loss, $14 million in cash, EVX-01 data plans and a runway into the second half of 2027.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.45/-0.31
Revenue / Forecast
0.00/0.00
Evaxion Biotech A/S Profile
SectorBiotechnology & Medical Research
Ticker SymbolEVAX
Number of employees46
CountryDenmark
Ownership
| Shareholders | Proportion |
|---|---|
| Merck & Co Inc | 14.56% |
| Merck Sharp & Dohme Corporation | 2.91% |
| PSM Vermögensverwaltung GmbH | 0.98% |
| Ikarian Capital LLC | 0.90% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 17.47% |
| Investment Advisor | 1.94% |
| Hedge Fund | 1.29% |
| Investment Advisor/Hedge Fund | 0.53% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%
FAQs
What is the current price of Evaxion Biotech A/S (EVAX)?
The current price of Evaxion Biotech A/S (EVAX) is 3.28.
What is the symbol of Evaxion Biotech A/S?
The ticker symbol of Evaxion Biotech A/S is EVAX.
What is the 52-week high of Evaxion Biotech A/S?
The 52-week high of Evaxion Biotech A/S is 12.15.
What is the 52-week low of Evaxion Biotech A/S?
The 52-week low of Evaxion Biotech A/S is 2.77.
What is the market capitalization of Evaxion Biotech A/S?
The market capitalization of Evaxion Biotech A/S is 29.59M.
Is Evaxion Biotech A/S (EVAX) currently rated as Buy, Hold, or Sell?
According to analysts, Evaxion Biotech A/S (EVAX) has an overall rating of Buy, with a price target of 11.25.
What is the Earnings Per Share (EPS TTM) of Evaxion Biotech A/S (EVAX)?
The Earnings Per Share (EPS TTM) of Evaxion Biotech A/S (EVAX) is -0.21.